15. Morel N., Levesque K., Maltret A., et al. Incidence, risk factors, and mortality of neonatal and late-onset dilated cardiomyopathy associated with cardiac neonatal lupus. Int J Cardiol. 2017; 248: 263-9.
16. Cuneo B.F., Fruitman D., Benson D.W., et al. Spontaneous rupture of atrioventricular valve tensor apparatus as late manifestation of anti-Ro/ SSA antibody-mediated cardiac disease. Am J Cardiol. 2011; 107: 761-6.
17. Heijstek V., Habib M., van der Palen R., van Doorn R., Muller P.H. Macrophage activation syndrome in a newborn: report of a case associated with neonatal lupus erythematosus and a summary of the literature. Pediatr Rheumatol. 2021; 19: 13.
18. Lin S.-C., Shyur S.-D., Huang L.-H., Wu J.-Y., Ma Y.-C. Focal seizures as an unusual presentation of neonatal lupus erythematosus. Asian Pac J Allergy Immunol. 2005; 23: 61-4.
19. Fredi M., Andreoli L., Bacco B., et al. First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) [Electronic resource]. Front Cardiovasc Med. 2019; 6. URL: https://www.frontiersin.org/articles/10.3389/fcvm.2019.00011/full (date of access 2021 February 17, 2012)
20. Buyon J.P., Clancy R.M., Friedman D.M. Autoimmune associated congenital heart block: integration of clinical and research clues in the management of the maternal/foetal dyad at risk. J Intern Med. 2009; 265: 653-62.
21. Ruffatti A., Cerutti A., Favaro M., et al. Plasmapheresis, intravenous immunoglobulins and bethametasone - a combined protocol to treat autoimmune congenital heart block: a prospective cohort study. Clin Exp Rheumatol. 2016; 34: 706-13.
22. Teixeira R.P., Neves A.L., Guimaraes H. Cardiac biomarkers in neonatology: BNP/NTproBNP, troponin I/T, CK-MB and myoglobin - a systematic review. J Pediatr Neonat Individual Med. 2017; 6 (2): e060219. DOI: https://doi.org/10.7363/060219
23. Ovsyannikov D.Yu., Malakhov A.B., Geppe N.A., Degtyarev D.N. Bronchopulmonary dysplasia. Monograph. Moscow, 2020. (in Russian)
24. Kryuchko D.S., Zubkov V.V., Degtyarev D.N., Ionov O.V., Nikitina I.V., Lenyushkina A.A., et al. Patent ductus arteriosus in premature infants. Tutorial. Moscow: GEOTAR-Media, 2019. (in Russian)
25. Bykova Y.K., Filippova E.A., Vatolin K.V., Ushakova L.V., Amirkhanova D.Y. Structural brain changes in case of hypoxic and ischemic central nervous system disorders in neonates of different gestational ages. Comparison of ultrasound images with morphological examination data. Neonatologiya: novosti, mneniya, obuchenie [Neonatology: News, Opinions, Training]. 2016; (3): 28-38. (in Russian)
26. Antonov A.G., Borisevich O.A., Burkova A.S., Ionov O.V., Kryuchko D.S., Lenyushkina A.A. Intensive care and nursing principles of neonates with extremely low and very low birth weight. In: E.N. Baybarina, D.N. Degtyareva, V.I. Shirokova (eds). Moscow, 2011. (in Russian)
27. Sanches B., Nunes P, Almeida H., Rebelo M. Atrioventricular block related to liposomal amphotericin B. BMJ Case Rep. 2014; 10: 113-6.
28. Kovalev I.A., Belozerov Yu.M., Sadykova D.I., et al. Atrioventricular block in children. Pediatricheskaya farmakologiya [Pediatric Pharmacology]. 2018; (15): 365-75. (in Russian)
29. Bokeria O.L. Electrical stimulation of the heart in children: monograph. Moscow: NMITs SSKh im. A.N. Bakuleva; Lan’, 2002. ISBN 5-79820100-7 (in Russian)
30. Zuppa A.A., Riccardi R., Frezza S., et al. Neonatal lupus: Follow-up in infants with anti-SSA/Ro antibodies and review of the literature. Auto-immun Rev. 2017; 16: 427-32.
31. Brito-Zeron P, Izmirly P.M., Ramos-Casals M., Buyon J.P., Khamashta M.A. The clinical spectrum of autoimmune congenital heart block. Nat Rev Rheumatol. 2015; 11: 301-12.
32. Saxena A., Izmirly P.M., Bomar R.P., et al. Factors associated with long-term cardiac dysfunction in neonatal lupus. Ann Rheum Dis. 2020; 79: 217-24.
33. Barsalou J., Jaeggi E., Laskin C.A., et al. Prenatal exposure to anti-malarials decreases the risk of cardiac but not non-cardiac neonatal lupus: a single-centre cohort study. Rheumatology. 2017; 56: 1552-9.
34. Levesque K., Morel N., Maltret A., et al. Description of 214 cases of autoimmune congenital heart block: Results of the French neonatal lupus syndrome. Autoimmun Rev. 2015; 14: 1154-60.
35. Trucco S.M., Jaeggi E., Cuneo B., et al. Use of intravenous gamma globulin and corticosteroids in the treatment of maternal autoantibody-mediated cardiomyopathy. J Am Coll Cardiol. 2011; 57: 715-23.
36. Izmirly P.M., Saxena A., Kim M.Y., et al. Maternal and fetal factors associated with mortality and morbidity in a multi-racial/ethnic registry of anti-SSA/Ro-associated cardiac neonatal lupus. Circulation. 2011; 124: 1927-35.
37. Friedman D.M., Kim M.Y., Copel J.A., et al. Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective study. Circulation. 2008; 117: 485-93.
38. Van den Berg N.W.E., Slieker M.G., van Beynum I.M., et al. Fluorinated steroids do not improve outcome of isolated atrioventricular block. Int J Cardiol. 2016; 225: 167-71.
39. Mofors J., Eliasson H., Ambrosi A., et al. Comorbidity and long-term outcome in patients with congenital heart block and their siblings exposed to Ro/SSA autoantibodies in utero. Ann Rheum Dis. 2019; 78: 696-703.
40. Jaeggi E.T., Hamilton R.M., Silverman E.D., Zamora S.A., Horn-berger L.K. Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block. J Am Coll Cardiol. 2002; 39: 130-7.
41. Izmirly P.M., Buyon J.P., Saxena A. Neonatal lupus: advances in understanding pathogenesis and identifying treatments of cardiac disease. Curr Opin Rheumatol. 2012; 24: 466-72.
42. Rumancik B., Haggstrom A.N., Ebenroth E.S. Neonatal lupus with left bundle branch block and cardiomyopathy: a case report. BMC Cardio-vasc Disord. 2020; 20: 352.
43. Wang Y.A., Sibbald C., Moon A.T. Retrospective, single-center case series of neonatal lupus. Pediatr Dermatol. 2020; 37: 484-9.
44. Klein-Gitelman M.S. Neonatal lupus: what we have learned and current approaches to care. Curr Rheumatol Rep. 2016; 18: 60.
45. Saxena A., Izmirly P.M., Han S.W., et al. Serum biomarkers of inflammation, fibrosis, and cardiac function in facilitating diagnosis, prognosis, and treatment of anti-SSA/Ro-associated cardiac neonatal lupus. J Am Coll Cardiol. 2015; 66: 930-9.
46. Gleason C.A., Juul S.E. Avery’s Diseases of the Newborn. 10th ed. Philadelphia: Elsevier, 2018.
47. Erchiga V.C., Florencio V.D. Malassezia species in skin diseases. Curr Opin Infect Dis. 2002; 15: 133-42.
48. Angiolella L., Leone C., Rojas F., Mussin J., de los Angeles Sosa M., Giusiano G. Biofilm, adherence, and hydrophobicity as virulence factors in Malassezia furfur. Med Mycol. 2018; 56: 110-6.
49. Nikitina I.V., Ionov O.V., Prikhod’ko N.A., Priputnevich T.V., Antonov A.G., Lyubasovskaya L.A., et al. Invasive mycoses in neonatology: prevention, diagnosis, and therapy. Akusherstvo i ginekologiya [Obstetrics and Gynecology]. 2015; (8): 18-25. (in Russian)
50. Hamprecht K., Goelz R. Postnatal cytomegalovirus infection through human milk in preterm infants: transmission, clinical presentation, and prevention. Clin Perinatol. 2017; 44: 121-30.
51. Schleiss M.R. Breast milk-acquired cytomegalovirus in premature infants: uncertain consequences and unsolved biological questions. JAMA Pediatr. 2020; 174: 121-3.
52. Garofoli F., Civardi E., Zanette S., et al. Literature review and an Italian hospital experience about post-natal CMV infection acquired by breast-feeding in very low and/or extremely low birth weight infants. Nutrients. 2021; 13: 660.